Ausgabe 8/2015
Inhalt (22 Artikel)
Defining a rational step-care algorithm for managing thyroid carcinoma patients with elevated thyroglobulin and negative on radioiodine scintigraphy (TENIS): considerations and challenges towards developing an appropriate roadmap
Sandip Basu, Mitali Dandekar, Amit Joshi, Anil D’Cruz
131I treatment for thyroid cancer and the risk of developing salivary and lacrimal gland dysfunction and a second primary malignancy: a nationwide population-based cohort study
Kuan-Yin Ko, Chia-Hung Kao, Cheng-Li Lin, Wen-Sheng Huang, Ruoh-Fang Yen
Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme
Eva-Maria Gamper, Lisa M. Wintner, Margarida Rodrigues, Sabine Buxbaum, Bernhard Nilica, Susanne Singer, Johannes M Giesinger, Bernhard Holzner, Irene Virgolini
Radioembolization with 90Y-loaded microspheres: high clinical impact of treatment simulation with MAA-based dosimetry
Etienne Garin
Fusion dual-tracer SPECT-based hepatic dosimetry predicts outcome after radioembolization for a wide range of tumour cell types
Marnix G. E. H. Lam, Arjun Banerjee, Michael L. Goris, Andrei H. Iagaru, Erik S. Mittra, John D. Louie, Daniel Y. Sze
A multicentre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization with resin microspheres
Kathy P. Willowson, Michael Tapner, Dale L. Bailey
Peptide receptor radionuclide therapy with 90Y/177Lu-labelled peptides for inoperable head and neck paragangliomas (glomus tumours)
Ameya D. Puranik, Harshad R. Kulkarni, Aviral Singh, Richard P. Baum
Towards tailored radiopeptide therapy
Piotr Radojewski, Rebecca Dumont, Nicolas Marincek, Philippe Brunner, Helmut R. Mäcke, Jan Müller-Brand, Matthias Briel, Martin A. Walter
Specific efficacy of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced neuroendocrine tumours of the small intestine
Amir Sabet, Kristina Dautzenberg, Torjan Haslerud, Anas Aouf, Amin Sabet, Birgit Simon, Karin Mayer, Hans-Jürgen Biersack, Samer Ezziddin
Usefulness of MRI-assisted metabolic volumetric parameters provided by simultaneous 18F-fluorocholine PET/MRI for primary prostate cancer characterization
Yong-il Kim, Gi Jeong Cheon, Jin Chul Paeng, Jeong Yeon Cho, Cheol Kwak, Keon Wook Kang, June-Key Chung, Euishin Edmund Kim, Dong Soo Lee
Thoracic staging of non-small-cell lung cancer using integrated 18F-FDG PET/MR imaging: diagnostic value of different MR sequences
Benedikt Schaarschmidt, Christian Buchbender, Benedikt Gomez, Christian Rubbert, Florian Hild, Jens Köhler, Johannes Grueneisen, Henning Reis, Verena Ruhlmann, Axel Wetter, Harald H. Quick, Gerald Antoch, Philipp Heusch
Preoperative risk stratification using metabolic parameters of 18F-FDG PET/CT in patients with endometrial cancer
Kazuhiro Kitajima, Yuko Suenaga, Yoshiko Ueno, Tetsuo Maeda, Yasuhiko Ebina, Hideto Yamada, Takashi Okunaga, Kazuhiro Kubo, Keitarou Sofue, Tomonori Kanda, Yukihisa Tamaki, Kazuro Sugimura
18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide
Ugo De Giorgi, Paola Caroli, Emanuela Scarpi, Vincenza Conteduca, Salvatore Luca Burgio, Cecilia Menna, Andrea Moretti, Riccardo Galassi, Lorena Rossi, Dino Amadori, Giovanni Paganelli, Federica Matteucci
68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
Francesco Ceci, Christian Uprimny, Bernhard Nilica, Llanos Geraldo, Dorota Kendler, Alexander Kroiss, Jasmin Bektic, Wolfgang Horninger, Peter Lukas, Clemens Decristoforo, Paolo Castellucci, Stefano Fanti, Irene J. Virgolini
ImmunoPET of tissue factor expression in triple-negative breast cancer with a radiolabeled antibody Fab fragment
Sixiang Shi, Hao Hong, Hakan Orbay, Stephen A. Graves, Yunan Yang, Jakob D. Ohman, Bai Liu, Robert J. Nickles, Hing C. Wong, Weibo Cai
Tumour targeting and radiation dose of radioimmunotherapy with 90Y-rituximab in CD20+ B-cell lymphoma as predicted by 89Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab
Kristoff Muylle, Patrick Flamen, Danielle J. Vugts, Thomas Guiot, Ghanem Ghanem, Nathalie Meuleman, Pierre Bourgeois, Bruno Vanderlinden, Guus A. M. S. van Dongen, Hendrik Everaert, Mélanie Vaes, Dominique Bron
Role of perfusion SPECT in prediction and measurement of pulmonary complications after radiotherapy for lung cancer
Katherina P. Farr, Stine Kramer, Azza A. Khalil, Anni Morsing, Cai Grau
V/P SPECT as a diagnostic tool for pregnant women with suspected pulmonary embolism
Marika Bajc, Berit Olsson, Anders Gottsäter, Cecilia Hindorf, Jonas Jögi
FDG PET/CT for bone and soft-tissue biopsy
Cristina Nanni, Alessandro Gasbarrini, Alberta Cappelli, Israel Sandler, Tiziano Graziani, Pierluigi Guidalotti, Rita Golfieri, Stefano Boriani, Stefano Fanti
Endotracheal metastasis from colorectal cancer
E. Tabacchi, P. Ghedini, S. Cambioli, P. Castellucci, S. Fanti
Erratum to: 18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide
Ugo De Giorgi, Paola Caroli, Emanuela Scarpi, Vincenza Conteduca, Salvatore Luca Burgio, Cecilia Menna, Andrea Moretti, Riccardo Galassi, Lorena Rossi, Dino Amadori, Giovanni Paganelli, Federica Matteucci